Apollomics Inc. va găzdui evenimente virtuale pentru investitori miercuri, 26 ianuarie 2022 și joi, 27 ianuarie 2022

Foster City, CA, Shanghai and Hangzhou, China, Jan 12, 2022 – (ACN Newswire) – Apollomics Inc. an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the management team will host two upcoming webcasts to accommodate participants from the U.S. and China. Co-Founder, Chairman and Chief Executive Officer, Guo-Liang Yu, PhD, will be joined by Sanjeev Redkar, PhD, Co-Founder and President, K. Peony Yu, M.D., Chief Medical Officer, and Wilson W. Cheung, CPA, Chief Financial Officer, to provide a strategic overview and an update on the Company's pipeline programs.

Session Dates/Times:

Session U.S. Pacific U.S. Eastern China Europe
English January 26th 11:00 a.m. January 26th 2:00 p.m. January 27th3:00 a.m. January 26th 8:00 p.m.
Chinese January 26th 7:00 p.m. January 26th 10:00 p.m. January 27th 11:00 a.m. January 27th 4:00 a.m.

All are invited to listen to the event and view the presentation via webcast on the Apollomics website under the News/Events section: Events and Presentations ( https://www.apollomicsinc.com/press-releases/events-presentations/ ). An archive of the webcast will be available for three months.

Despre Apollomics Inc.

Apollomics Inc. este o companie biofarmaceutică inovatoare dedicată descoperirii și dezvoltării de monoterapii și terapii combinate de agenți de țintire a tumorilor și imuno-oncologici. Gama de produse a companiei are mai multe programe în diferite stadii de dezvoltare, inclusiv noi anticorpi monoclonali umanizați care refac sistemul imunitar al organismului pentru a recunoaște și ucide celulele canceroase și terapii direcționate împotriva căilor de semnalizare a creșterii necontrolate. Apollomics are entități de operare în Foster City, California, SUA, Hangzhou și Shanghai, China. Pentru mai multe informatii va rugam vizitati www.apollomicsinc.com.

Informații de contact:

Investitor Contact:
Wilson W. Cheung
Chief Financial Officer
(650) 209-4436
wcheung@apollomicsinc.com

Contact media SUA:
Remy Bernarda
comunicații corporatiste
(415) 203-6386
remy.bernarda@apollomicsinc.com

Contact mass-media din China:
Porda Havas International Finance Communications Group
Kelly Fung
Director General
(852) 3150 6763
kelly.fung@pordahavas.com


Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comApollomics Inc. an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the management team will host two upcoming webcasts to accommodate participants from the U.S. and China. Sursă: https://www.acnnewswire.com/press-release/english/72359/